Provider
P14-18 Delay of Second Phase Transition with Magellan
Program effective Date: May 01, 2018
Search Results
Displaying 3171 - 3180 of 3689 results
Provider
P30-17 New Drug-Related Prior Authorization (PA) Criteria: Topical Retinoids
Program effective Date: Jun 05, 2017
Provider
P41-18 Update: Change to TPA Business
Program effective Date: Sep 04, 2018
Provider
P69-17 New Reimbursement Policy for Inpatient Facility: Inpatient Short Stay
Program effective Date: Nov 13, 2017
Provider
P74-17 Payment Methodology Change for Interim Billing
Program effective Date: Nov 29, 2017
Provider
P51-18 Lab Management Program CPT Code Update for Fully Insured Commercial Members - eviCore Healthcare Specialty Utilization Management (UM) Program
Program effective Date: Oct 01, 2018
Provider
P52-17 New Drug-Related Prior Authorization with Quantity Limit Criteria: Parathyroid Hormone Analog for Osteoporosis
Program effective Date: Oct 03, 2017
Provider
P9-17 A New Drug, Ingrezza (valbenazine) Will Require Prior Authorization
Program effective Date: Mar 21, 2017
Provider
P44-17 New Drug-Related Prior Authorization and Quantity Limit Criteria: Opioid, Buprenorphine Concurrent Therapy
Program effective Date: Aug 14, 2017
Provider
P16-17 Changes in Medical Policy IV-107 Hip Arthroplasty (Hip Replacement) and Hip Resurfacing
Program effective Date: Apr 28, 2017